Consider the following statements regarding Accountability in autonomous gene-editing technologies:
1. The 2003 Human Genome Project completion coincided with the establishment of the Global Observatory for Gene Editing, which functions as the primary enforcement agency for tracking unauthorized germline modifications.
2. The 1975 Asilomar Conference on Recombinant DNA provided the initial safety guidelines for synthetic biology, and these protocols currently serve as the legal foundation for regulating autonomous gene-editing laboratories in the European Union.
3. The 2010 Nagoya Protocol on Access and Benefit-sharing includes specific clauses regarding the digital sequence information of human embryos, effectively governing the commercialization of autonomous gene-editing software.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the Global Observatory for Gene Editing is an independent research initiative, not an enforcement agency, and it was established long after the 2003 Human Genome Project. Statement 2 is incorrect as the 1975 Asilomar Conference focused on voluntary safety guidelines for recombinant DNA research, which are not legally binding protocols for modern autonomous gene-editing regulation in the EU. Statement 3 is incorrect because the 2010 Nagoya Protocol pertains to genetic resources and traditional knowledge, and it does not contain specific clauses governing the commercialization of digital sequence information for human embryos.
Consider the following statements regarding Accountability in autonomous gene-editing technologies:
1. The 2018 Second International Summit on Human Genome Editing concluded with a consensus statement that germline editing for clinical reproductive purposes remains premature due to safety and ethical concerns.
2. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights established the International Bioethics Committee, which serves as the primary judicial body for resolving gene-editing patent disputes.
3. The 2015 International Summit on Human Gene Editing in Washington D.C. resulted in the adoption of the Cartagena Protocol, which provides a framework for the cross-border regulation of CRISPR-Cas9 applications.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is correct as the 2018 Summit emphasized that germline editing remains premature due to significant scientific and ethical uncertainties. Statement 2 is incorrect because the International Bioethics Committee (IBC) is an advisory body to UNESCO, not a judicial authority for patent disputes, which are handled by bodies like the WIPO. Statement 3 is incorrect because the Cartagena Protocol (2000) focuses on the safe transfer and handling of Living Modified Organisms (LMOs) resulting from modern biotechnology, not specifically on the regulation of CRISPR-Cas9 applications.
Consider the following statements regarding Genetic privacy and data ownership in genomic medicine:
1. The 2001 Human Genome Project completion report includes provisions for the public release of sequence data and establishes that individual researchers hold the patent rights to identified genetic markers.
2. The 1948 Nuremberg Code provides for the protection of human subjects in clinical trials and includes provisions for the ownership of genomic data derived from participants in international research collaborations.
3. The 2013 Nagoya Protocol on Access and Benefit Sharing refers to the utilization of genetic resources and encompasses the transfer of digital sequence information to private entities without prior informed consent.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the Human Genome Project emphasized open-access data to prevent patenting of raw genetic sequences, contrary to individual researcher ownership. Statement 2 is incorrect as the 1948 Nuremberg Code focuses on voluntary consent and ethical conduct in medical experimentation, not the ownership of genomic data. Statement 3 is incorrect because the Nagoya Protocol mandates 'Prior Informed Consent' and 'Mutually Agreed Terms' for the utilization of genetic resources, explicitly prohibiting the unauthorized transfer of such information.
Consider the following statements regarding The concept of genetic essentialism and discrimination:
1. The 2015 International Summit on Human Gene Editing concluded that germline editing is acceptable for the enhancement of cognitive traits, provided the research is conducted under the supervision of the World Health Organization.
2. The 1997 Oviedo Convention, which entered into force in 1999, provides for the modification of the human genome in germline cells provided that the intervention is approved by a national ethics committee.
3. Genetic determinism is a concept often associated with the 1990 Human Genome Project launch, which proposed that the identification of all 3 billion base pairs would allow for the accurate prediction of an individual's personality traits.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the 2015 International Summit concluded that germline editing for clinical use is currently irresponsible, explicitly opposing enhancement. Statement 2 is false as the Oviedo Convention (Article 13) strictly prohibits any intervention seeking to introduce any modification in the genome of any descendants. Statement 3 is incorrect because, while the Human Genome Project aimed to map the human genome, it never claimed that the 3 billion base pairs could accurately predict complex personality traits, which are influenced by a multifaceted interplay of genes and environment.
Consider the following statements regarding Eugenics and the slippery slope of human enhancement:
1. The 1975 Asilomar Conference on Recombinant DNA provided the foundational guidelines for clinical gene therapy, leading to the first successful somatic cell trial in 1980.
2. The 1998 UNESCO Universal Declaration on the Human Genome and Human Rights identifies the human genome as the common heritage of humanity and permits germline intervention for therapeutic purposes.
3. The 2017 Hinxton Group consensus statement supports the use of CRISPR-Cas9 for reproductive purposes, provided the procedures are conducted within academic medical centers.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the 1975 Asilomar Conference focused on biosafety risks of recombinant DNA research rather than clinical gene therapy, and the first successful somatic cell trial occurred in 1990, not 1980. Statement 2 is incorrect because the 1998 UNESCO Declaration explicitly prohibits germline interventions that could be contrary to human rights, rather than permitting them. Statement 3 is incorrect because the 2017 Hinxton Group statement maintained that germline genome editing for clinical reproductive purposes is currently premature and unsafe, explicitly advising against such applications at that time.
Consider the following statements regarding Pre-implantation genetic diagnosis and designer babies:
1. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights addresses the social responsibility of states to facilitate access to quality health care and essential medicines.
2. The 1997 UNESCO Universal Declaration on the Human Genome and Human Rights provides for the creation of an international monitoring body, and the 2005 Declaration on Bioethics subsequently established a permanent tribunal for enforcing genetic research protocols.
3. In 2017, the U.S. National Academy of Sciences released a report suggesting that germline editing might be permitted in the future for serious conditions under stringent oversight.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 3 is correct. Statement 2 is incorrect.
Statement 1 is correct as the 2005 UNESCO Declaration explicitly emphasizes the social responsibility of states to improve access to quality healthcare and essential medicines. Statement 3 is correct because the 2017 U.S. National Academy of Sciences report cautiously opened the door for germline editing, provided it is restricted to treating serious diseases under rigorous regulatory oversight. Statement 2 is incorrect because, while the 1997 Declaration promotes international cooperation, neither it nor the 2005 Declaration established a permanent tribunal or an international monitoring body with enforcement powers for genetic research.
Consider the following statements regarding Therapeutic intervention versus genetic enhancement:
1. The 2001 Human Genome Project completion announcement included a provision that allows for the patenting of naturally occurring genetic sequences if they are utilized in therapeutic gene therapy applications.
2. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights, in Article 15, emphasizes the importance of sharing benefits resulting from scientific research with developing countries.
3. In 2018, the Second International Summit on Human Genome Editing concluded that germline editing for enhancement purposes remains ethically unacceptable given current scientific limitations.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 2 is correct. Statement 3 is correct. Statement 1 is incorrect.
Statement 1 is incorrect because the Human Genome Project explicitly prohibited the patenting of naturally occurring genetic sequences to ensure open access for research. Statement 2 is correct as Article 15 of the 2005 UNESCO Declaration mandates that benefits from scientific research should be shared with society and the international community, particularly with developing countries. Statement 3 is correct because the 2018 Summit reached a global consensus that germline editing for enhancement is irresponsible and ethically unacceptable due to safety risks and the potential for exacerbating social inequalities.
Consider the following statements regarding Accountability in autonomous gene-editing technologies:
1. The 2021 WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing identified the lack of a centralized registry as a primary barrier to international accountability.
2. Article 13 of the 1997 UNESCO Universal Declaration on the Human Genome and Human Rights states that practices which are contrary to human dignity, such as reproductive cloning, shall not be permitted.
3. The 1996 Oviedo Convention on Human Rights and Biomedicine includes a specific annex regarding the use of autonomous AI in gene-editing procedures, which was ratified by the United States to harmonize international research standards.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is incorrect.
Statement 1 is correct as the 2021 WHO report emphasized that a global registry is essential for transparency and accountability in human genome editing. Statement 2 is correct because Article 13 of the 1997 UNESCO Declaration explicitly prohibits practices contrary to human dignity, including reproductive cloning. Statement 3 is incorrect because the 1996 Oviedo Convention does not contain an annex on autonomous AI, and the United States has neither signed nor ratified the Convention, as it is a regional treaty primarily open to Council of Europe member states.
Consider the following statements regarding Germline versus somatic cell genome editing:
1. Somatic cell therapies for sickle cell disease, such as the 2023 FDA-approved Casgevy, rely on germline modification techniques to ensure the long-term persistence of corrected hematopoietic stem cells.
2. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights provides for the protection of future generations, and its Article 15 allows for the clinical application of germline editing under national regulatory frameworks.
3. CRISPR-Cas9 technology, first described in a 2012 study by Doudna and Charpentier, utilizes a guide RNA to direct the Cas9 nuclease to specific genomic sequences.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 3 is correct. Statement 1 is incorrect. Statement 2 is incorrect.
Statement 3 is correct because the landmark 2012 study by Jennifer Doudna and Emmanuelle Charpentier established the CRISPR-Cas9 system as a programmable genome-editing tool using guide RNA to direct the Cas9 nuclease. Statement 1 is incorrect because Casgevy involves somatic cell therapy, which modifies non-reproductive cells and is not passed to offspring, whereas germline editing involves heritable changes to embryos or gametes. Statement 2 is incorrect because, while the UNESCO Declaration emphasizes the protection of future generations, it does not explicitly authorize the clinical application of germline editing; in fact, there is a broad international scientific consensus and regulatory moratorium against the clinical use of germline modifications due to profound ethical and safety concerns.
Consider the following statements regarding Non-maleficence in clinical gene editing trials:
1. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights identifies the principle of minimizing harm as a central pillar for the ethical conduct of scientific research.
2. Article 13 of the 1997 Oviedo Convention prohibits any intervention seeking to introduce a modification in the genome of any descendants, citing the principle of non-maleficence.
3. In 2018, the World Health Organization established an Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing to address safety risks.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 2005 UNESCO Declaration explicitly mandates that research must maximize benefit and minimize harm. Statement 2 is correct because Article 13 of the 1997 Oviedo Convention (the only international legally binding instrument on the protection of human rights in the biomedical field) prohibits germline genome editing to prevent potential irreversible harm to future generations. Statement 3 is correct as the WHO established this Expert Advisory Committee in 2018 specifically to develop a global governance framework for human genome editing, addressing the ethical and safety challenges highlighted by the He Jiankui affair.
Consider the following statements regarding Pre-implantation genetic diagnosis and designer babies:
1. The 1997 UNESCO Universal Declaration on the Human Genome and Human Rights states that the human genome in its symbolic state should not be subject to financial gain.
2. Pre-implantation genetic diagnosis (PGD) was first successfully performed in 1989 by Alan Handyside to identify sex-linked genetic disorders.
3. In 2018, He Jiankui reported the birth of twin girls whose CCR5 genes were modified using CRISPR-Cas9 technology to confer resistance to HIV.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as Article 4 of the 1997 UNESCO Declaration explicitly prohibits the human genome from being a source of financial gain. Statement 2 is accurate because Alan Handyside successfully performed the first clinical PGD in 1989 to screen embryos for X-linked recessive diseases. Statement 3 is correct as He Jiankui's 2018 experiment involved using CRISPR-Cas9 to edit the CCR5 gene in twin embryos to create HIV-resistant individuals, a move that sparked global ethical controversy.
Consider the following statements regarding Equity in global genomic data representation:
1. The Global Alliance for Genomics and Health (GA4GH) established its framework in 2013 to promote the responsible sharing of genomic data across international borders.
2. The 2015 International Summit on Human Gene Editing established a binding global registry for all clinical trials involving germline modifications to prevent regional bias in research data.
3. The 2019 Lancet Commission report noted that over 80 percent of genome-wide association studies have been conducted on populations of European descent.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 3 is correct. Statement 2 is incorrect.
Statement 1 is correct as GA4GH was indeed founded in 2013 to foster international genomic data sharing standards. Statement 3 is correct, reflecting the widely cited disparity in genomic research where the vast majority of participants are of European ancestry, leading to significant health equity gaps. Statement 2 is incorrect because the 2015 International Summit on Human Gene Editing did not establish a binding global registry; while it called for international dialogue, there is currently no legally binding global registry for germline modification trials.
Consider the following statements regarding Interspecies chimera research and moral status:
1. The 2018 Second International Summit on Human Genome Editing resulted in a consensus document, and it serves as the primary enforcement mechanism for the global prohibition of germline modifications.
2. The 2015 International Summit on Human Gene Editing concluded that germline editing research should not proceed until safety concerns are addressed and broad societal consensus is reached.
3. In 2019, researchers at the Salk Institute successfully generated human-monkey chimeric embryos, which were cultured for up to 20 days to study early embryonic development.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 2 is correct. Statement 3 is correct. Statement 1 is incorrect.
Statement 2 is correct as the 2015 International Summit established a moratorium on clinical germline editing until safety and societal consensus are achieved. Statement 3 is correct because, in 2019, Salk Institute researchers successfully developed human-monkey chimeric embryos to study interspecies development. Statement 1 is incorrect because the 2018 Summit did not create a binding enforcement mechanism; rather, it emphasized international dialogue, and there is no global legal prohibition on germline modifications, only varying national regulations.
Consider the following statements regarding Interspecies chimera research and moral status:
1. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights addresses the protection of non-human primates, and it provides a legal mechanism for the international regulation of chimera research.
2. The 1975 Asilomar Conference on Recombinant DNA focused on the containment of biohazardous agents, and it introduced the first binding global protocol for the creation of human-animal hybrids.
3. The 1947 Nuremberg Code establishes the ethical framework for interspecies research, and it was formally ratified by the United Nations General Assembly in 1948 to govern genetic modification.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
All three statements are incorrect because none of the cited documents address interspecies chimera research or genetic modification in the manner described. The 2005 UNESCO Declaration focuses on human rights and bioethics without providing binding legal mechanisms for chimera research; the 1975 Asilomar Conference established voluntary safety guidelines for recombinant DNA research rather than global protocols for human-animal hybrids; and the 1947 Nuremberg Code was established solely to govern human experimentation following World War II, not genetic modification.
Consider the following statements regarding Regulatory frameworks for synthetic biology:
1. The 2000 Cartagena Protocol on Biosafety covers the transboundary movement of synthetic organisms, and the 2012 amendment extended these provisions to include human germline editing.
2. The 1975 Asilomar Conference on Recombinant DNA established the international safety standards for synthetic biology, and these guidelines were formally adopted by the WHO in 1982.
3. The 1992 Convention on Biological Diversity includes provisions for the patenting of synthetic genomes, and the 2005 implementation guidelines define the scope of proprietary bio-digital assets.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
All three statements are incorrect because the Cartagena Protocol (2000) focuses on Living Modified Organisms (LMOs) and does not cover human germline editing; the 1975 Asilomar Conference was a voluntary scientific gathering that produced guidelines for recombinant DNA research, but these were never formally adopted as international law by the WHO; and the 1992 Convention on Biological Diversity (CBD) primarily addresses the conservation and sustainable use of biodiversity, containing no provisions for patenting synthetic genomes or defining bio-digital assets.
Consider the following statements regarding Bio-security risks of dual-use genetic research:
1. The 2018 Second International Summit on Human Genome Editing resulted in a consensus statement that clinical use of germline editing remains premature due to safety and ethical concerns.
2. Article IV of the 1972 Biological Weapons Convention prohibits the development, production, and stockpiling of biological agents for non-peaceful purposes.
3. The 1975 Asilomar Conference on Recombinant DNA established initial safety guidelines for genetic engineering, emphasizing the containment of potentially hazardous biological agents.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 2018 Summit concluded that germline editing is premature due to risks of off-target effects and ethical implications. Statement 2 is correct because Article IV of the 1972 Biological Weapons Convention mandates that states parties take necessary measures to prohibit and prevent the development, production, and stockpiling of biological agents for non-peaceful purposes. Statement 3 is correct as the 1975 Asilomar Conference was a landmark event that established the first safety guidelines for recombinant DNA research, focusing on physical and biological containment to manage potential biosafety risks.
Consider the following statements regarding Genetic privacy and data ownership in genomic medicine:
1. Article 9 of the 1997 Oviedo Convention establishes that the previously expressed wishes of a patient regarding a medical intervention shall be taken into account if the patient is not in a state to express their will.
2. The 2003 International Declaration on Human Genetic Data, adopted by UNESCO, emphasizes that genetic data should not be used for purposes that discriminate against individuals or groups.
3. The 1964 Declaration of Helsinki is associated with the ethical principles for medical research involving human subjects and provides for the automatic transfer of data ownership to the funding institution upon project completion.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is incorrect.
Statement 1 is correct as Article 9 of the 1997 Oviedo Convention mandates that the previously expressed wishes of a patient unable to express their will must be considered. Statement 2 is correct because the 2003 UNESCO International Declaration on Human Genetic Data explicitly prohibits the use of genetic data for discriminatory purposes against individuals or groups. Statement 3 is incorrect because the 1964 Declaration of Helsinki focuses on the ethical principles of medical research and patient protection, but it does not contain any provisions mandating the automatic transfer of data ownership to funding institutions.
Consider the following statements regarding Bioethical implications of CRISPR-based gene drives:
1. The 2018 report by the National Academies of Sciences, Engineering, and Medicine identified that gene drive systems could potentially alter or suppress entire populations of disease-carrying mosquitoes.
2. Article 8(g) of the 1992 Convention on Biological Diversity encourages parties to regulate, manage, or control the risks associated with the use and release of living modified organisms.
3. The 2016 IUCN World Conservation Congress in Hawaii adopted Motion 086, which initiated a formal assessment of the potential risks and benefits of synthetic biology, including CRISPR-based gene drives.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
All three statements are correct: the 2018 NASEM report confirmed the potential of gene drives to suppress malaria-carrying mosquitoes; Article 8(g) of the Convention on Biological Diversity mandates the regulation of living modified organisms to prevent environmental harm; and the 2016 IUCN Motion 086 formally tasked the organization with assessing the conservation implications of synthetic biology and gene drive technologies. There are no incorrect statements provided in the question.
Consider the following statements regarding Informed consent in pediatric genetic interventions:
1. In the 2018 report by the Nuffield Council on Bioethics, it is noted that germline genome editing in children carries potential risks that may manifest only in future generations.
2. The 2015 International Summit on Human Gene Editing concluded that clinical use of germline editing in children remains premature due to current limitations in safety and efficacy data.
3. Section 4 of the 2001 CIOMS International Ethical Guidelines for Health-related Research Involving Humans states that researchers should involve children in the decision-making process according to their developmental stage.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 2018 Nuffield Council report emphasizes the intergenerational risks of germline modifications, which cannot be consented to by future individuals. Statement 2 is correct because the 2015 International Summit reached a consensus that clinical germline editing is irresponsible until safety and efficacy are established and broad societal consensus is achieved. Statement 3 is correct as the CIOMS guidelines mandate that children be involved in the assent process for research, respecting their evolving capacity for decision-making.
Consider the following statements regarding Ethical status of human embryos in research:
1. The 1990 Human Genome Project included a specific mandate for the ethical oversight of synthetic embryos, establishing the current international consensus on the moral status of the pre-implantation embryo.
2. The 2015 International Summit on Human Gene Editing concluded that germline editing is currently safe for clinical use, provided that the embryos are not cultured beyond the blastocyst stage.
3. The 1947 Nuremberg Code provides the foundational framework for modern embryo research, specifically addressing the informed consent of gamete donors in IVF procedures.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the 1990 Human Genome Project focused on mapping human DNA, not synthetic embryos, and no global consensus on the moral status of embryos exists. Statement 2 is false as the 2015 International Summit explicitly concluded that germline editing is not safe for clinical use due to risks of off-target effects and lack of societal consensus. Statement 3 is incorrect because the 1947 Nuremberg Code was established to address Nazi medical war crimes and human experimentation, not IVF or embryo research, which emerged decades later.
Consider the following statements regarding CRISPR-Cas9 off-target mutation risks:
1. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights provides a framework for genomic research and establishes that any modification of the human germline is considered a violation of the right to biological integrity.
2. The 2020 Nobel Prize in Chemistry was awarded for the development of the CRISPR-Cas9 method, which researchers utilize to achieve precise genome editing by ensuring that the guide RNA binds to the target site without secondary interactions.
3. The 2016 NIH policy on human gene transfer research requires that investigators submit data from whole-genome sequencing to verify that CRISPR-Cas9 has induced no detectable structural variations in the patient's genome.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the 2005 UNESCO Declaration promotes ethical standards but does not explicitly ban germline editing as a violation of biological integrity. Statement 2 is incorrect because, while CRISPR-Cas9 won the 2020 Nobel Prize, off-target mutations remain a significant technical challenge, as guide RNA frequently binds to unintended sites with similar sequences. Statement 3 is incorrect because the NIH does not mandate whole-genome sequencing for all human gene transfer research to verify the absence of structural variations, as such a requirement is currently neither standardized nor universally feasible.
Consider the following statements regarding Interspecies chimera research and moral status:
1. The 1997 Oviedo Convention represents the first legally binding international instrument on the protection of human rights in the biomedical field, and it contains specific provisions for the creation of human-animal chimeras.
2. The 2003 Human Genome Project completion marked the establishment of the International Bioethics Committee, and it provides the standardized criteria for evaluating the moral status of sentient chimeric organisms.
3. The 1964 Declaration of Helsinki, as amended in 2013, provides that the health of the research subject takes precedence over all other interests in medical research involving human participants.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 3 is correct. Statement 1 is incorrect. Statement 2 is incorrect.
Statement 3 is correct because the 1964 Declaration of Helsinki, a cornerstone of medical ethics, explicitly mandates that the well-being of the individual research subject must always take precedence over the interests of science and society. Statement 1 is incorrect because while the 1997 Oviedo Convention is the only international legally binding instrument on human rights in biomedicine, it does not contain specific provisions for the creation of human-animal chimeras. Statement 2 is incorrect because the International Bioethics Committee (IBC) was established by UNESCO in 1993, not in 2003, and there is currently no internationally standardized criteria for evaluating the moral status of chimeric organisms.
Consider the following statements regarding The concept of genetic essentialism and discrimination:
1. The 1997 UNESCO Universal Declaration on the Human Genome and Human Rights asserts that the human genome is in a symbolic sense the heritage of humanity, protecting individuals against genetic discrimination.
2. The 2003 International Declaration on Human Genetic Data defines genetic essentialism as a clinical condition, and it encourages states to integrate genetic screening into public health insurance programs.
3. The 1948 Universal Declaration of Human Rights includes specific provisions regarding the protection of the human genome, which served as the primary legal basis for the 1997 UNESCO declaration on genetic data.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is correct because the 1997 UNESCO Declaration explicitly declares the human genome as the 'heritage of humanity' to prevent reductionist approaches and discrimination. Statement 2 is incorrect because genetic essentialism is a philosophical concept regarding the overestimation of genetic influence, not a clinical condition, and the 2003 Declaration actually emphasizes protecting genetic data privacy rather than mandating universal screening. Statement 3 is incorrect because the 1948 Universal Declaration of Human Rights predates the discovery of the double helix structure of DNA and contains no provisions regarding the human genome.
Consider the following statements regarding Equity in global genomic data representation:
1. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights emphasizes the importance of sharing the benefits of scientific research with developing countries.
2. The 2003 Human Genome Project completion report provided for the immediate inclusion of diverse indigenous genomic sequences to ensure global representation in the final reference map.
3. The 2018 Genome Aggregation Database (gnomAD) reported that individuals of European ancestry constitute approximately 78 percent of the total genomic data entries.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 3 is correct. Statement 2 is incorrect.
Statement 1 is correct as the 2005 UNESCO Declaration explicitly advocates for the equitable sharing of scientific benefits to prevent the exploitation of developing nations. Statement 3 is correct because historical biases in genomic research have led to a significant overrepresentation of European ancestry in databases like gnomAD, often exceeding 75-80%. Statement 2 is incorrect because the 2003 Human Genome Project primarily utilized a small number of anonymous donors, largely failing to include diverse indigenous sequences, which has necessitated subsequent initiatives like the '1000 Genomes Project' to address this representation gap.
Consider the following statements regarding Genetic privacy and data ownership in genomic medicine:
1. In the 2017 case of Justice K.S. Puttaswamy v. Union of India, the Supreme Court of India recognized informational privacy as a facet of the right to life and personal liberty under Article 21 of the Constitution.
2. The 2005 Universal Declaration on Bioethics and Human Rights, under Article 15, provides that the benefits of scientific research should be shared with society as a whole and within the international community.
3. The 2018 Indian Council of Medical Research (ICMR) National Ethical Guidelines for Biomedical and Health Research specify that biological samples and associated data can be stored for future research only with broad participant consent.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the landmark 2017 Puttaswamy judgment established informational privacy as a fundamental right under Article 21. Statement 2 is correct because Article 15 of the 2005 UNESCO Universal Declaration on Bioethics and Human Rights mandates the sharing of scientific benefits with society and the international community. Statement 3 is correct as the 2018 ICMR guidelines explicitly permit the storage of biological samples and data for future research provided that broad consent is obtained from the participants.
Consider the following statements regarding Non-maleficence in clinical gene editing trials:
1. The 1947 Nuremberg Code provides the foundational framework for clinical trials, and its third section establishes the specific protocols for germline gene editing safety assessments.
2. The 2017 National Academy of Sciences report on human genome editing suggests that somatic cell trials fall under the regulatory purview of the 1998 Kyoto Protocol on environmental safety.
3. The 2015 International Summit on Human Gene Editing concluded that clinical applications are permissible provided that the 1975 Belmont Report guidelines on therapeutic substitution are followed.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the Nuremberg Code (1947) focuses on voluntary consent and does not contain specific protocols for germline gene editing, a technology developed decades later. Statement 2 is false as the 2017 NAS report focuses on human health ethics, whereas the 1998 Kyoto Protocol is an international treaty exclusively addressing greenhouse gas emissions and climate change. Statement 3 is incorrect because the 2015 International Summit explicitly recommended against clinical germline editing until safety and ethical concerns are resolved, and the Belmont Report (1979) addresses the protection of human subjects, not 'therapeutic substitution'.
Consider the following statements regarding Non-maleficence in clinical gene editing trials:
1. The 2021 International Commission on the Clinical Use of Human Germline Genome Editing identifies the 1966 International Covenant on Civil and Political Rights as the primary legal mechanism for monitoring off-target mutation risks.
2. The 2019 WHO registry for human genome editing encompasses all global clinical trials and provides for the automatic certification of safety protocols under the 1948 Universal Declaration of Human Rights.
3. The 1964 Declaration of Helsinki, revised in 2013, emphasizes that the health of the individual patient remains the primary consideration in clinical research involving gene editing.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 3 is correct. Statement 1 is incorrect. Statement 2 is incorrect.
Statement 3 is correct because the 1964 Declaration of Helsinki, as updated in 2013, mandates that the well-being of the individual research subject must take precedence over all other interests in clinical studies. Statement 1 is incorrect because the 2021 International Commission report does not designate the 1966 ICCPR as a mechanism for monitoring off-target mutations; rather, it focuses on scientific governance and ethical oversight. Statement 2 is incorrect because the WHO registry for human genome editing, established in 2021, is a transparency platform and does not provide automatic certification of safety protocols under the 1948 Universal Declaration of Human Rights.
Consider the following statements regarding Transgenerational impact of heritable genetic modifications:
1. The 1997 UNESCO Universal Declaration on the Human Genome and Human Rights asserts that the human genome is the heritage of humanity and discourages practices contrary to human dignity.
2. Article 13 of the 1997 Oviedo Convention prohibits any intervention seeking to introduce any modification in the genome of any descendants.
3. In 2018, the Second International Summit on Human Genome Editing concluded that germline editing remains premature due to the risk of off-target effects and unintended transgenerational consequences.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 1997 UNESCO Declaration defines the human genome as the 'heritage of humanity' and explicitly warns against practices that violate human dignity. Statement 2 is correct because Article 13 of the Oviedo Convention (the only international legally binding instrument on the subject) strictly prohibits interventions intended to modify the genome of any descendants. Statement 3 is correct as the 2018 Second International Summit concluded that germline editing is scientifically and ethically premature, citing significant risks of off-target mutations and the unpredictable nature of transgenerational genetic inheritance.
Consider the following statements regarding Therapeutic intervention versus genetic enhancement:
1. The 2003 International Declaration on Human Genetic Data, adopted by the UNESCO General Conference, permits the commercialization of human germline cells provided that the donor receives a share of the royalties.
2. The 1964 Declaration of Helsinki, revised in 2013, distinguishes between therapeutic research intended to benefit the patient and non-therapeutic research aimed at scientific knowledge.
3. The 1947 Nuremberg Code establishes the principle of informed consent and provides for the legal authorization of genetic enhancement in cases involving hereditary disease prevention.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 2 is correct. Statement 1 is incorrect. Statement 3 is incorrect.
Statement 2 is correct because the Declaration of Helsinki (1964, revised 2013) explicitly mandates that medical research involving human subjects must balance the potential benefits to the individual patient against the pursuit of scientific knowledge. Statement 1 is incorrect because the 2003 UNESCO Declaration prohibits the commercialization of human genetic data and germline cells, emphasizing that the human genome is the heritage of humanity. Statement 3 is incorrect because the 1947 Nuremberg Code focuses solely on the ethics of human experimentation and informed consent, containing no provisions for the legal authorization of genetic enhancement.
Consider the following statements regarding Regulatory frameworks for synthetic biology:
1. The 2010 Nagoya Protocol on Access and Benefit-sharing provides a legal framework for the utilization of genetic resources, including those derived from synthetic biology research.
2. Article 15 of the Cartagena Protocol on Biosafety addresses the risk assessment of living modified organisms, which serves as a foundational reference for synthetic biology oversight.
3. The 2016 International Gene Editing Summit in Washington D.C. resulted in a global moratorium on clinical germline applications, which remains the primary regulatory document for synthetic biology.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is incorrect.
Statement 1 is correct as the Nagoya Protocol (2010) mandates fair and equitable sharing of benefits arising from genetic resources, extending to digital sequence information used in synthetic biology. Statement 2 is correct because Article 15 of the Cartagena Protocol mandates that risk assessments for living modified organisms be conducted in a scientifically sound manner, forming the global benchmark for synthetic biology safety. Statement 3 is incorrect because the 2016 Summit expressed caution regarding germline editing but did not establish a legally binding global moratorium, as international governance on synthetic biology remains fragmented rather than governed by a single primary document.
Consider the following statements regarding Commercialization and patenting of genetic sequences:
1. The 1998 EU Directive 98/44/EC on the legal protection of biotechnological inventions clarifies that biological material isolated from its natural environment is patentable even if it previously occurred in nature.
2. Article 27.3(b) of the TRIPS Agreement allows member nations to exclude plants and animals, other than microorganisms, from patentability, provided they offer protection for plant varieties through an effective sui generis system.
3. The 2013 US Supreme Court ruling in Association for Molecular Pathology v. Myriad Genetics invalidated patents on naturally occurring human DNA sequences while upholding patents on complementary DNA.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as EU Directive 98/44/EC explicitly permits the patenting of isolated biological elements, distinguishing them from mere discoveries. Statement 2 is correct because Article 27.3(b) of the TRIPS Agreement grants WTO members the flexibility to exclude plants and animals from patentability, provided they implement an effective sui generis system for plant varieties. Statement 3 is correct as the US Supreme Court in the Myriad Genetics case ruled that naturally occurring DNA segments are products of nature and ineligible for patenting, whereas synthetic complementary DNA (cDNA) is patent-eligible because it is not naturally occurring.
Consider the following statements regarding Bio-security risks of dual-use genetic research:
1. The 2016 report by the U.S. National Academies of Sciences, Engineering, and Medicine identified gene drives as a technology with significant dual-use potential for both ecological control and environmental disruption.
2. The 1993 Chemical Weapons Convention, while focused on chemicals, established the Organization for the Prohibition of Chemical Weapons (OPCW) which serves as a structural model for verifying dual-use biological research compliance.
3. Section 12 of the 2004 Australia Group common control lists includes specific genetic elements and modified organisms that are subject to export licensing for biosecurity reasons.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 2016 NASEM report highlighted gene drives as 'dual-use' due to their ability to eradicate invasive species or potentially collapse ecosystems if misused. Statement 2 is correct because the OPCW's rigorous verification and inspection framework is frequently cited as the gold standard for monitoring dual-use research in the Biological Weapons Convention (BWC) discourse. Statement 3 is correct as the Australia Group, an informal multilateral export control regime, maintains comprehensive control lists (Section 12) specifically covering human, animal, and plant pathogens, along with genetic elements and modified organisms, to prevent the proliferation of biological weapons.
Consider the following statements regarding Germline versus somatic cell genome editing:
1. In 2019, the World Health Organization established a global registry to track all human genome editing research, both clinical and preclinical.
2. Article 13 of the 1997 Oviedo Convention prohibits any intervention seeking to introduce any modification in the genome of any descendants.
3. The 2021 WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing identified 12 key recommendations for ethical research.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the WHO established a global registry in 2019 to enhance transparency and oversight in human genome editing research. Statement 2 is accurate because Article 13 of the 1997 Oviedo Convention explicitly forbids modifications to the human genome that could be passed on to descendants, effectively banning germline editing. Statement 3 is correct because the 2021 WHO Expert Advisory Committee report established a comprehensive framework consisting of 12 key recommendations to guide the ethical governance and oversight of both somatic and germline human genome editing.
Consider the following statements regarding Equity in global genomic data representation:
1. The H3Africa initiative, launched in 2010, focuses on developing infrastructure for genomic research within African nations to address the current underrepresentation in global datasets.
2. Article 15 of the 2005 UNESCO Declaration advocates for the equitable distribution of scientific knowledge to mitigate the impact of genomic disparities on global health outcomes.
3. The 2010 Nagoya Protocol includes provisions for the fair and equitable sharing of benefits arising from genetic resources and covers human genomic data within its primary regulatory scope.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is incorrect.
Statement 1 is correct as the H3Africa initiative, established in 2010, aims to build sustainable genomic research capacity across Africa to rectify the historical exclusion of African populations in genomic studies. Statement 2 is correct because Article 15 of the 2005 UNESCO Universal Declaration on Bioethics and Human Rights explicitly promotes the sharing of scientific knowledge and benefits to reduce health inequities. Statement 3 is incorrect because the Nagoya Protocol specifically excludes human genetic resources from its scope, focusing instead on the fair and equitable sharing of benefits arising from the utilization of genetic resources in plants, animals, and microbes.
Consider the following statements regarding Transgenerational impact of heritable genetic modifications:
1. The 2019 report by the Nuffield Council on Bioethics provides for the ethical use of heritable genome editing to prevent serious genetic diseases, provided the procedure is performed within the first trimester of embryonic development.
2. The 2017 report by the U.S. National Academy of Sciences supports the use of CRISPR-Cas9 for heritable germline changes in cases where the clinical condition is linked to a single gene mutation identified in the 2003 Human Genome Project.
3. The 1948 Nuremberg Code encompasses the ethical standards for clinical research and includes provisions for the informed consent of future generations in studies involving transgenerational genetic alterations.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the Nuffield Council report emphasizes that heritable genome editing is not currently safe or ethically acceptable for clinical use, regardless of the developmental stage. Statement 2 is incorrect as the 2017 U.S. National Academy of Sciences report strictly limits germline editing to research purposes only, not clinical application, and does not restrict it to 2003 Human Genome Project data. Statement 3 is incorrect because the 1948 Nuremberg Code focuses on voluntary consent for human subjects in medical experimentation and contains no provisions for the impossible task of obtaining informed consent from future generations.
Consider the following statements regarding Regulatory frameworks for synthetic biology:
1. The 2014 WHO guidance on laboratory biosafety encompasses the regulation of synthetic biology, and the 2019 update provides for the mandatory registration of all private synthetic biology research facilities.
2. The 2003 International Treaty on Plant Genetic Resources for Food and Agriculture provides for the regulation of synthetic gene drives, and the 2018 review session expanded its mandate to laboratory-grown meat.
3. The 1998 UNESCO Universal Declaration on the Human Genome and Human Rights addresses the modification of the human germline, and the 2003 revision provides the technical framework for CRISPR-Cas9 application.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
All three statements are incorrect because they misattribute regulatory mandates to existing international frameworks. The 2014 WHO biosafety guidance does not mandate private facility registration, the 2003 Plant Treaty focuses on genetic resources rather than gene drives or lab-grown meat, and the 1998 UNESCO Declaration has never been revised to include technical CRISPR-Cas9 frameworks. These international instruments serve as ethical or biodiversity-focused guidelines rather than specific regulatory or technical protocols for synthetic biology.
Consider the following statements regarding Germline versus somatic cell genome editing:
1. The 2018 Second International Summit on Human Genome Editing concluded that clinical application of germline editing is currently irresponsible due to safety concerns.
2. Somatic cell genome editing involves modifications restricted to non-reproductive cells, meaning the genetic changes are not passed to future generations.
3. The 1948 Universal Declaration of Human Rights includes provisions regarding genetic integrity, and the 1997 Oviedo Convention serves as its primary enforcement mechanism for germline editing.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is incorrect.
Statement 1 is correct as the 2018 Summit concluded that germline editing was premature due to safety and ethical risks, while Statement 2 is correct because somatic modifications affect only the individual patient and are not heritable. Statement 3 is incorrect because the 1948 Universal Declaration of Human Rights does not contain provisions on genetic integrity, and the 1997 Oviedo Convention, while significant, is a regional Council of Europe treaty rather than a global enforcement mechanism for the Declaration.
Consider the following statements regarding Bio-security risks of dual-use genetic research:
1. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights outlines the principle of protecting the environment, the biosphere, and biodiversity in the context of genetic advancements.
2. The 1975 Asilomar Conference concluded with the formal adoption of the Cartagena Protocol on Biosafety, which governs the international movement of living modified organisms resulting from modern biotechnology.
3. The 2017 WHO guidance on the responsible life sciences research for global health security addresses the risks of dual-use research of concern (DURC) in genomic technologies.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 3 is correct. Statement 2 is incorrect.
Statement 1 is correct as the 2005 UNESCO Declaration explicitly emphasizes the protection of the biosphere and biodiversity in Article 17. Statement 3 is correct because the 2017 WHO guidance framework provides essential oversight for Dual-Use Research of Concern (DURC) to mitigate biosecurity threats. Statement 2 is incorrect because the 1975 Asilomar Conference focused on establishing safety guidelines for recombinant DNA research, whereas the Cartagena Protocol was adopted much later in 2000 under the Convention on Biological Diversity.
Consider the following statements regarding Cultural and religious perspectives on human genome alteration:
1. The 1997 UNESCO Universal Declaration on the Human Genome and Human Rights asserts that the human genome is in a symbolic sense the heritage of humanity.
2. Article 13 of the 1997 Oviedo Convention prohibits any intervention seeking to introduce any modification in the genome of any descendants.
3. In 2018, the Second International Summit on Human Genome Editing concluded that clinical use of germline editing remains premature due to safety and ethical concerns.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 1997 UNESCO Declaration explicitly defines the human genome as the 'heritage of humanity' to prevent commercial exploitation. Statement 2 is correct because Article 13 of the Oviedo Convention specifically bans germline modifications that would be passed on to future generations. Statement 3 is correct as the 2018 Summit, prompted by the He Jiankui controversy, reached a global consensus that germline editing is currently unsafe and ethically unacceptable for clinical application.
Consider the following statements regarding Commercialization and patenting of genetic sequences:
1. The 2001 UNESCO Universal Declaration on the Human Genome and Human Rights states that the human genome in its natural state shall not give rise to financial gains.
2. The Nagoya Protocol, adopted in 2010, establishes a framework for Access and Benefit Sharing (ABS) regarding the utilization of genetic resources to ensure fair distribution of commercial gains.
3. The 1992 Convention on Biological Diversity introduced the concept of 'digital sequence information' as a formal category for patent eligibility, establishing the first global registry for synthetic gene sequences.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is incorrect.
Statement 1 is correct as Article 4 of the 1997 UNESCO Declaration explicitly states that the human genome in its natural state shall not give rise to financial gains. Statement 2 is correct because the 2010 Nagoya Protocol provides a legal framework for the fair and equitable sharing of benefits arising from the utilization of genetic resources. Statement 3 is incorrect because the 1992 Convention on Biological Diversity focuses on the conservation and sustainable use of biodiversity, whereas 'digital sequence information' is a recent, complex, and still-debated topic under the CBD framework, not a category established in 1992.
Consider the following statements regarding Distributive justice in access to gene therapies:
1. The 2019 WHO Registry on Human Genome Editing functions as a centralized clearinghouse that provides for the automatic licensing of gene therapies to low-income countries upon successful clinical trial completion.
2. The 2021 UNESCO Recommendations on the Ethics of Artificial Intelligence encompasses the regulation of gene-editing software and established a universal baseline for the fair distribution of genetic diagnostic tools.
3. The 2003 Human Genome Project completion announcement included a provision that prohibits private biotechnology firms from holding intellectual property rights over sequences identified during the mapping process.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the WHO Registry is a transparency tool for tracking research, not a licensing mechanism for automatic distribution. Statement 2 is incorrect as the 2021 UNESCO Recommendations focus on AI ethics rather than gene-editing software regulation. Statement 3 is incorrect because the Human Genome Project did not prohibit intellectual property rights; in fact, the subsequent 'Bermuda Principles' and patent filings by private entities like Celera Genomics highlighted the ongoing controversy over patenting genetic sequences.
Consider the following statements regarding CRISPR-Cas9 off-target mutation risks:
1. The 2019 WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing recommended that all clinical applications of CRISPR utilize high-fidelity variants like Cas12a to eliminate the possibility of off-target activity.
2. The 2017 FDA guidelines on gene therapy products categorize CRISPR-Cas9 as a small molecule drug, allowing for the expedited approval of clinical trials that demonstrate a 95 percent reduction in off-target mutation rates.
3. The 2015 International Summit on Human Gene Editing concluded that the primary risk of CRISPR-Cas9 is the unintended integration of the viral vector into the host genome, rather than the generation of point mutations at non-target loci.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
All three statements are incorrect because the WHO's 2019 committee focused on establishing a global registry and governance framework rather than mandating specific variants like Cas12a, which still carry inherent off-target risks. The FDA classifies CRISPR-based therapies as biologics rather than small molecule drugs, and there is no regulatory threshold of a 95 percent reduction for expedited approval. Furthermore, the 2015 International Summit identified the primary risks of CRISPR-Cas9 as both off-target mutations and mosaicism, explicitly cautioning against the unintended genetic alterations at non-target loci rather than focusing solely on viral vector integration.
Consider the following statements regarding Transgenerational impact of heritable genetic modifications:
1. The 2021 WHO expert advisory committee report on human genome editing identified the need for a global registry to track germline interventions and monitor long-term health outcomes in offspring.
2. The 2015 International Summit on Human Gene Editing in Washington D.C. resulted in a binding protocol that permits therapeutic germline modifications provided they are registered with the World Health Organization.
3. The 2005 UNESCO Declaration on Bioethics and Human Rights establishes the framework for international patenting of modified germline sequences to ensure equitable access for developing nations.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is correct as the 2021 WHO report emphasized a global registry for human genome editing to ensure transparency and monitor long-term safety. Statement 2 is incorrect because the 2015 International Summit concluded that clinical use of germline editing is currently irresponsible, and no binding international protocol permits it. Statement 3 is incorrect because the 2005 UNESCO Declaration focuses on protecting human dignity and human rights, explicitly discouraging the commercialization of the human genome rather than facilitating the patenting of germline sequences.
Consider the following statements regarding Pre-implantation genetic diagnosis and designer babies:
1. The Oviedo Convention, opened for signature in 1997, remains the only international legally binding instrument for the protection of human rights in the biomedical field.
2. As of 2023, the World Health Organization's expert advisory committee on human genome editing has proposed a global registry to track both somatic and germline clinical trials.
3. The 2003 International Declaration on Human Genetic Data emphasizes the importance of informed consent for the collection and storage of genetic samples.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the Oviedo Convention, adopted by the Council of Europe in 1997, remains the sole international treaty addressing human rights in biomedicine. Statement 2 is correct because the WHO expert advisory committee, established in 2018, explicitly recommended a global registry for all human genome editing research to ensure transparency and ethical oversight. Statement 3 is correct as the 2003 UNESCO Declaration on Human Genetic Data mandates that genetic data collection must be preceded by free, informed, and express consent to protect individual autonomy and privacy.
Consider the following statements regarding Therapeutic intervention versus genetic enhancement:
1. The 1975 Asilomar Conference on Recombinant DNA focused on the containment of laboratory pathogens and introduced the first global regulatory framework for human genetic enhancement procedures.
2. The 1997 Oviedo Convention, specifically Article 13, prohibits interventions seeking to introduce any modification in the genome of any descendants.
3. The 2016 report by the Nuffield Council on Bioethics distinguishes between somatic and germline editing, suggesting that germline intervention is a recognized clinical standard for treating adult-onset muscular dystrophy.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 2 is correct. Statement 1 is incorrect. Statement 3 is incorrect.
Statement 2 is correct as Article 13 of the 1997 Oviedo Convention explicitly prohibits genome modifications in descendants (germline editing). Statement 1 is incorrect because the 1975 Asilomar Conference focused on laboratory safety and recombinant DNA research, not human genetic enhancement. Statement 3 is incorrect because the Nuffield Council on Bioethics report maintains a cautious stance on germline editing, which is not a recognized clinical standard for muscular dystrophy; such treatments currently focus on somatic gene therapy.
Consider the following statements regarding Eugenics and the slippery slope of human enhancement:
1. The 2003 Human Genome Project completion report proposed the creation of an international registry for germline modifications, which currently operates under the auspices of the United Nations.
2. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights emphasizes the protection of future generations and the preservation of human biodiversity in Article 16.
3. In 2018, the Second International Summit on Human Genome Editing concluded that clinical use of germline editing remains premature due to safety and ethical concerns.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 2 is correct. Statement 3 is correct. Statement 1 is incorrect.
Statement 1 is incorrect because no such international registry for germline modifications currently operates under the United Nations. Statement 2 is correct as Article 16 of the 2005 UNESCO Declaration explicitly addresses the impact of life sciences on future generations and the necessity of protecting biodiversity. Statement 3 is correct because the 2018 Summit, triggered by the He Jiankui affair, established a global consensus that germline editing is scientifically and ethically premature for clinical application.
Consider the following statements regarding Eugenics and the slippery slope of human enhancement:
1. The 1948 Nuremberg Code established the first international framework for genetic screening, which was later incorporated into the 1964 Declaration of Helsinki.
2. The 2015 International Summit on Human Gene Editing resulted in a formal moratorium on all CRISPR-based research, which was ratified by the World Health Organization in 2016.
3. The 1997 Oviedo Convention, specifically Article 13, prohibits interventions seeking to introduce any modification in the genome of any descendants.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 3 is correct. Statement 1 is incorrect. Statement 2 is incorrect.
Statement 3 is correct because the 1997 Oviedo Convention, the only international legally binding instrument on the protection of human rights in the biomedical field, explicitly prohibits germline modifications in Article 13. Statement 1 is incorrect because the 1948 Nuremberg Code focused on ethical principles for human experimentation in response to Nazi atrocities, not genetic screening. Statement 2 is incorrect because the 2015 International Summit did not issue a total moratorium on all CRISPR research; it instead called for a cautious approach and established a framework for ongoing dialogue, without a formal WHO-ratified ban.
Consider the following statements regarding Cultural and religious perspectives on human genome alteration:
1. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights encompasses the principle of informed consent, and it is recognized as a treaty that carries direct enforcement powers for signatory nations.
2. The 1997 UNESCO Declaration on the Human Genome and Human Rights provides for the protection of genetic data, and it was ratified by the United States Senate during the 106th Congress.
3. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights emphasizes the importance of cultural diversity and pluralism in the context of scientific advancements.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 3 is correct. Statement 1 is incorrect. Statement 2 is incorrect.
Statement 3 is correct as the 2005 UNESCO Declaration explicitly recognizes cultural diversity and pluralism as essential considerations in bioethical discourse. Statement 1 is incorrect because the 2005 Declaration is a non-binding instrument and does not possess direct enforcement powers over signatory nations. Statement 2 is incorrect because the 1997 Declaration is a soft-law instrument adopted by the UNESCO General Conference, not a treaty ratified by the United States Senate.
Consider the following statements regarding Bioethical implications of CRISPR-based gene drives:
1. The 2015 statement by the International Summit on Human Gene Editing concluded that it would be irresponsible to proceed with any clinical use of germline editing until safety issues are addressed.
2. The 2022 Kunming-Montreal Global Biodiversity Framework includes Target 17, which focuses on the management of risks associated with the use and release of living modified organisms resulting from biotechnology.
3. Section 14 of the 2019 report by the High-Level Panel of Experts on Food Security and Nutrition addresses the potential ecological impacts of gene-edited crops on biodiversity.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 2015 International Summit on Human Gene Editing established a global consensus against clinical germline editing due to safety and ethical concerns. Statement 2 is correct because Target 17 of the 2022 Kunming-Montreal Global Biodiversity Framework explicitly mandates the management of biotechnological risks, including living modified organisms, to prevent adverse impacts on biodiversity. Statement 3 is correct as the 2019 HLPE report on Food Security and Nutrition highlights the ecological risks and biodiversity implications associated with the deployment of gene-edited crops in agricultural systems.
Consider the following statements regarding The concept of genetic essentialism and discrimination:
1. Genetic essentialism is defined in sociological literature as the tendency to reduce an individual's identity, behavior, or potential to their genetic makeup, often ignoring environmental or social factors.
2. The 2018 report by the Nuffield Council on Bioethics noted that the use of genome editing in human reproduction could potentially exacerbate existing social inequalities if access is restricted by socioeconomic status.
3. Article 6 of the 2005 UNESCO Universal Declaration on Bioethics and Human Rights emphasizes that any preventive, diagnostic, or therapeutic medical intervention is to be carried out only with the prior, free, and informed consent of the person concerned.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as genetic essentialism posits that genes determine human traits, disregarding the complex interplay of environmental and social influences. Statement 2 is correct because the 2018 Nuffield Council report explicitly warned that unequal access to germline genome editing could create a 'genetic divide,' deepening existing socioeconomic disparities. Statement 3 is correct as Article 6 of the 2005 UNESCO Declaration mandates that all medical interventions, including those involving genetic technologies, must strictly adhere to the principle of free and informed consent to protect human dignity and autonomy.
Consider the following statements regarding Informed consent in pediatric genetic interventions:
1. The 1964 Declaration of Helsinki, revised in 2013, emphasizes that for pediatric research, the assent of the minor should be obtained in addition to the informed consent of the legal guardian.
2. The 1990 Human Genome Project initiated the first global registry for pediatric gene therapy, which was later incorporated into the 1996 HIPAA privacy regulations for medical data.
3. The 1947 Nuremberg Code includes provisions for pediatric genetic testing, and it established the first legal framework for proxy consent in clinical trials during the 1952 amendments.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is correct because the 1964 Declaration of Helsinki (revised 2013) mandates that for research involving minors, the researcher must obtain the minor's assent in addition to the legally authorized representative's informed consent. Statement 2 is incorrect as the Human Genome Project did not initiate a global registry for pediatric gene therapy, nor were such registries incorporated into the 1996 HIPAA regulations. Statement 3 is incorrect because the 1947 Nuremberg Code focused on voluntary consent for competent adults and contained no provisions for pediatric genetic testing or proxy consent, which were developed in much later ethical frameworks.
Consider the following statements regarding Ethical status of human embryos in research:
1. The 1978 birth of Louise Brown led to the 1984 Warnock Report, which proposed a 21-day limit for embryo experimentation to align with the completion of the primitive streak.
2. The 1997 Oviedo Convention, specifically Article 18, prohibits the creation of human embryos for research purposes in signatory states.
3. The 2018 He Jiankui affair involved the use of CRISPR-Cas9 on germline cells, which was permitted under the 2003 Chinese Ministry of Health guidelines regarding clinical reproductive research.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 2 is correct. Statement 1 is incorrect. Statement 3 is incorrect.
Statement 2 is correct as the 1997 Oviedo Convention explicitly prohibits the creation of human embryos for research purposes to protect human dignity. Statement 1 is incorrect because the Warnock Report recommended a 14-day limit, not 21 days, corresponding to the appearance of the primitive streak. Statement 3 is incorrect because the He Jiankui affair violated existing Chinese regulations and international scientific consensus, which strictly prohibited germline editing for clinical reproductive purposes.
Consider the following statements regarding Distributive justice in access to gene therapies:
1. The 2018 Second International Summit on Human Genome Editing concluded that clinical use of germline editing remains premature due to significant safety concerns and lack of broad societal consensus.
2. The 2015 International Summit on Human Gene Editing in Washington D.C. resulted in the adoption of a legally binding protocol that restricts the commercial patenting of somatic cell editing techniques.
3. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights provides for equitable access to medical technology and established a global fund for the distribution of CRISPR-based therapies to developing nations.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is correct as the 2018 Second International Summit concluded that germline editing was premature due to safety and ethical concerns. Statement 2 is incorrect because the 2015 Summit did not produce a legally binding protocol, as international summits on gene editing generally provide non-binding ethical frameworks rather than enforceable treaties. Statement 3 is incorrect because, while the 2005 UNESCO Declaration promotes equitable access to medical progress, it did not establish a global fund for the distribution of CRISPR-based therapies.
Consider the following statements regarding Ethical status of human embryos in research:
1. The International Society for Stem Cell Research (ISSCR) 2021 guidelines maintain the '14-day rule' as a threshold for culturing human embryos in laboratory settings.
2. The 2016 Hinxton Group statement on genome editing suggests that germline modification is acceptable if the procedure follows the 2008 Human Fertilisation and Embryology Act standards for clinical implementation.
3. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights emphasizes the protection of future generations, including the genetic constitution of human beings.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 3 is correct. Statement 2 is incorrect.
Statement 1 is correct because the 2021 ISSCR guidelines relaxed the strict 14-day rule, allowing for case-by-case review of experiments beyond 14 days, effectively modifying the previous absolute threshold. Statement 3 is correct as the 2005 UNESCO Declaration explicitly calls for the protection of future generations and the preservation of the human genetic constitution. Statement 2 is incorrect because the Hinxton Group and international consensus generally maintain that germline modification is currently premature and unsafe for clinical implementation, rather than endorsing it under the 2008 Act.
Consider the following statements regarding Cultural and religious perspectives on human genome alteration:
1. The 2015 International Summit on Human Genome Editing established a global moratorium on all gene-editing research, and it remains the primary regulatory framework for clinical trials in the European Union.
2. The 1948 Universal Declaration of Human Rights includes specific provisions regarding genetic privacy, and it was updated in 2002 to address the emergence of CRISPR-Cas9 technologies.
3. The 1997 Oviedo Convention provides for the protection of human rights in the biomedical field, and it currently serves as a legally binding instrument for all member states of the United Nations.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the 2015 Summit did not establish a global moratorium but rather cautioned against clinical use of germline editing, and it is not a regulatory framework for the EU. Statement 2 is incorrect as the 1948 Universal Declaration of Human Rights predates modern genetic science and has never been updated to include CRISPR-Cas9 provisions. Statement 3 is incorrect because the 1997 Oviedo Convention is a Council of Europe treaty, not a legally binding instrument for all United Nations member states.
Consider the following statements regarding Commercialization and patenting of genetic sequences:
1. The 2005 UNESCO Declaration on Bioethics and Human Rights provides for the mandatory international registration of all private gene-editing patents to prevent the monopolization of therapeutic CRISPR applications.
2. The 2010 Nagoya Protocol includes provisions that grant indigenous communities direct veto power over the commercialization of genetic data derived from flora found within their ancestral territories.
3. Under the 1995 TRIPS Agreement, the World Intellectual Property Organization serves as the primary judicial body for resolving disputes involving the patenting of human embryonic stem cell lines.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is incorrect. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is incorrect because the 2005 UNESCO Declaration is a non-binding instrument that emphasizes human dignity and social responsibility rather than establishing a mandatory international registry for patents. Statement 2 is incorrect as the Nagoya Protocol focuses on 'Access and Benefit-Sharing' (ABS) regarding genetic resources, requiring informed consent and mutually agreed terms, but it does not grant indigenous communities an absolute veto power over commercialization. Statement 3 is incorrect because the TRIPS Agreement is administered by the WTO, not WIPO, and disputes are settled through the WTO's Dispute Settlement Body, not a judicial body specifically for stem cell patents.
Consider the following statements regarding Distributive justice in access to gene therapies:
1. Article 13 of the 1997 UNESCO Universal Declaration on the Human Genome and Human Rights states that research, including applications in the field of biology and genetics, should aim to relieve suffering and improve the health of individuals and humankind as a whole.
2. The 2017 WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing issued a report that formalizes the international pricing structure for gene-based orphan drugs.
3. The 2008 Oviedo Convention, while focusing on biomedical research, includes a specific annex that permits germline modifications for the purpose of preventing hereditary diseases in member states.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is incorrect. Statement 3 is incorrect.
Statement 1 is correct as Article 13 of the 1997 UNESCO Declaration explicitly mandates that genetic research should prioritize the relief of suffering and the improvement of human health. Statement 2 is incorrect because the 2017 WHO committee focused on establishing global governance and oversight frameworks for human genome editing, not on setting international pricing structures for orphan drugs. Statement 3 is incorrect because the 1997 Oviedo Convention (not 2008) strictly prohibits any intervention seeking to modify the human genome that would be passed on to descendants, explicitly banning germline modifications.
Consider the following statements regarding Bioethical implications of CRISPR-based gene drives:
1. The 2021 WHO guidance document on human genome editing emphasizes that the use of germline editing in clinical settings remains premature due to unresolved safety and ethical concerns.
2. In 2020, the Cartagena Protocol on Biosafety held its tenth meeting of the parties, where discussions centered on the risk assessment frameworks for organisms containing gene drives.
3. The 2017 DARPA Safe Genes program allocated approximately 65 million dollars to develop molecular countermeasures for controlling the spread of gene-edited organisms in the environment.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 1 is correct. Statement 2 is correct. Statement 3 is correct.
Statement 1 is correct as the 2021 WHO report explicitly advises against clinical germline editing due to significant safety risks and ethical uncertainties. Statement 2 is correct because the COP-MOP 10 of the Cartagena Protocol extensively deliberated on the regulatory and risk assessment frameworks for living modified organisms, including gene drives. Statement 3 is correct as the 2017 DARPA Safe Genes program was indeed launched with a $65 million investment to engineer genetic 'brakes' and countermeasures to control or reverse the spread of gene-edited organisms.
Consider the following statements regarding CRISPR-Cas9 off-target mutation risks:
1. The Cartagena Protocol on Biosafety, adopted in 2000, covers the transboundary movement of living modified organisms and includes specific provisions for the mandatory reporting of CRISPR-induced off-target effects in agricultural gene drives.
2. The 2012 Doudna-Charpentier study in Science demonstrated that the Cas9 protein utilizes a dual-RNA structure for DNA cleavage, which functions with 100 percent fidelity in human embryonic stem cells.
3. The 2018 report by the International Commission on the Clinical Use of Human Germline Genome Editing identified that CRISPR-Cas9 systems exhibit off-target mutations at sites with high sequence homology to the intended target sequence.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 3 is correct. Statement 1 is incorrect. Statement 2 is incorrect.
Statement 3 is correct as the 2018 International Commission report highlighted that CRISPR-Cas9 often induces off-target mutations at sites sharing high sequence homology with the target DNA. Statement 1 is incorrect because the Cartagena Protocol focuses on the transboundary movement of Living Modified Organisms (LMOs) and does not contain specific mandates for reporting CRISPR-induced off-target effects. Statement 2 is incorrect because, while the 2012 Doudna-Charpentier study established the dual-RNA mechanism, it did not claim 100 percent fidelity, as CRISPR-Cas9 is well-documented to have inherent risks of off-target activity.
Consider the following statements regarding Informed consent in pediatric genetic interventions:
1. The 2003 completion of the Human Genome Project led to the adoption of the 2004 WHO Guidelines on Genetic Counseling, which allows for mandatory genetic screening of newborns in developing nations.
2. The 2005 UNESCO Universal Declaration on Bioethics and Human Rights provides that special protection is to be given to persons who do not have the capacity to consent, including children.
3. Article 6 of the 1997 Oviedo Convention on Human Rights and Biomedicine specifies that an intervention on a person not able to consent may be carried out only for his or her direct benefit.
How many of the statements given above are correct?
- Only one
- Only two
- All three
- None
Explanation: Statement 2 is correct. Statement 3 is correct. Statement 1 is incorrect.
Statement 1 is incorrect because the 2004 WHO guidelines emphasize voluntary participation and autonomy, explicitly rejecting mandatory genetic screening. Statement 2 is correct as Article 7 of the 2005 UNESCO Declaration mandates special protection for individuals lacking the capacity to consent, ensuring their interests are prioritized. Statement 3 is correct because Article 6 of the 1997 Oviedo Convention strictly limits medical interventions on persons unable to consent to those that provide a direct health benefit to the individual.